ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as ABI-007, work in different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well ABI-007 works in treating patients with
inoperable (unresectable) locally recurrent or metastatic melanoma.